The liposome development and manufacturing services market is valued at USD 0.7 billion in the year 2022 and is poised for an impressive compounded annual growth rate (CAGR) of 9.7% during the forecast period.

A notable 90% of the drug candidates currently navigating the development pipeline, alongside nearly 40% of pharmaceutical products that have already found their place in the market, grapple with issues pertaining to solubility and permeability. Hence, participants within the pharmaceutical sphere are diligently engaged in the pursuit of strategies to enhance and refine the physiochemical attributes and drug-like characteristics of pharmaceutical products. Amidst the spectrum of available solutions, the spotlight now shines on liposomes, owing to their capacity to augment the permeability across biological membranes.

Liposomes, diminutive artificial vesicles, exhibit the unique capability to encapsulate, transport, and dispense drugs with low solubility and petite molecules to precise anatomical locations within the body. Over the passage of time, numerous scientific inquiries have unveiled the remarkable potential of liposomes in realms ranging from disease diagnostics to drug conveyance. Their capacity to spontaneously assemble, carry substantial drug payloads, function as biomarkers for an array of ailments, and facilitate the transfer of pivotal functional components has garnered much admiration. Such virtues have ensnared the attention of the biopharmaceutical sector, hinting at an upsurge in demand in the days to come. Nonetheless, the terrain of liposome development and manufacturing is riddled with its fair share of obstacles. These hurdles include intricate manufacturing processes, substantial financial investments, insufficiencies in clinical-grade production aligned with Good Manufacturing Practice (GMP) standards, a paucity of infrastructure-equipped facilities, and reservations revolving around storage and longevity.

Given these aforementioned challenges, several pharmaceutical enterprises have exhibited a distinct preference for outsourcing their liposome development and manufacturing endeavors to specialized service providers.

Key Market Segments

Type of Product Formulation

  • Therapeutic
  • Nutraceutical


Scale of Operation

  • Discovery / Research
  • Preclinical
  • Clinical
  • Commercial
  • End User

Pharmaceutical and Biotechnology

  • Cosmetics
  • Food
  • Agricultural
  • Academic
  • Other Industries

Geographic Regions

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and North Africa


Research Coverage:

  • The report studies the liposome manufacturing market by type of product formulation, scale of operation, end user and key geographical regions
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market
  • The report forecasts the revenue of market segments with respect to major regions
  • An overview of key findings from our research on the liposome manufacturing market, offering insights into its current state and likely evolution in the short, mid, and long term.
  • A meticulous assessment of the dynamic landscape governing the liposome development and manufacturing service providers that hinges on a variety of pertinent parameters, encompassing the establishment year, the dimensions of the company in terms of its workforce, geographical headquarters, the methods adopted for liposome preparation, the spectrum of services offered, the specific targets for liposome bioconjugation, scalability options, techniques employed for liposome analysis and characterization, the spectrum of applications, and the scale of operation, in addition to a comprehensive overview of the end-users.
  • An in-depth examination of the expansive landscape of clinical studies related to liposomes that discerns the trends manifest across diverse parameters, such as the year of trial registration, trial status, the phase of the trial, types of sponsors/collaborators, study design, key players, disease indications, therapeutic areas, treatment modalities, emerging focal points, and the regional distribution of trials.
  • A meticulous review of over 6,000 peer-reviewed scientific articles in the realm of liposome research. These articles are scrutinized through the lenses of pertinent parameters, such as the year of publication, application areas, emerging focal points, and a spotlight on the leading journals in terms of publications and impact factor.
  • The patent landscape pertaining to liposomes, spanning from 2017 onwards, encompasses an array of parameters, including the type of patent, year of publication, the distinction between granted patents and patent applications, geographical considerations, CPC symbols, emerging focus areas, organizational affiliations, leading players in terms of patent activities, and distinctive patent characteristics. A profound patent benchmarking exercise supplements this analysis, culminating in an insightful valuation analysis that spotlights pivotal patents based on citation frequency.
  • A comprehensive analysis offers a perceptive "go/no-go" framework for outsourcing decisions, elucidating the factors to be considered by liposome developers when deliberating between in-house production and engagement with a Contract Manufacturing Organization (CMO). It further dissects key parameters relevant to companies of varying sizes, guiding their choices in this pivotal decision-making process.


Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the liposome manufacturing market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
  • You will get access to complimentary PPT insights and excel data packs / dynamic dashboards to easily navigate through complex analyses / charts.


Key Market Companies

  • Baxter BioPharma Solutions
  • Charles River Laboratories
  • Evonik
  • Fresenius Kabi
  • GEA
  • Intertek
  • Fujifilm